EMS — Prescription Medicines
Provider 
Founded 1964
Sells To Consumers, Healthcare Providers, Hospitals
Pricing Model B2B, Product Sales
Ownership Family-owned, Private

Prescription medicines from EMS for pharmacists, physicians and healthcare professionals across practically all medical specialties.
EMS Prescrição is the prescription-medicines unit of Brazilian pharmaceutical manufacturer EMS, aimed at pharmacists, physicians and other healthcare professionals. It forms part of the company's portfolio of roughly 1,100+ presentations across practically all medical specialties.
The unit's 2026 innovation line includes GLP-1 injectable pens such as semaglutide (Ozivy) and liraglutide, launched in Brazil with Becton Dickinson. Products are dispensed through the retail pharmacy channel to patients holding a medical prescription.
Eurofarma

Eurofarma Oncologia, Eurofarma Produtos
eurofarma.com.br
Cristália

Farma Retail Prescription Medicines
cristalia.com.br
Servier

Servier Produtos
servier.com.br
| Attribute | EMS — Prescription Medicines | Eurofarma Oncologia, Eurofarma Produtos | Farma Retail Prescription Medicines | Servier Produtos | |
|---|---|---|---|---|---|
| Provider | |||||
| Founded | 1964 | 1972 | 1972 | — | |
| Sells To | Consumers, Healthcare Providers, Hospitals | Consumers | Consumers, Hospitals | — | |
| Pricing Model | B2B, Product Sales | Recurring, Software, Transactional | Product Sales | — | |
| Ownership | Family-owned, Private | Public | Private | — |
Provider 
Founded 1964
Sells To Consumers, Healthcare Providers, Hospitals
Pricing Model B2B, Product Sales
Ownership Family-owned, Private
Provider 
Founded 1972
Sells To Consumers
Pricing Model Recurring, Software, Transactional
Ownership Public
Provider 
Founded 1972
Sells To Consumers, Hospitals
Pricing Model Product Sales
Ownership Private
Provider 
Founded —
Sells To —
Pricing Model —
Ownership —


Medley manufactures generic medicines in Brazil, offering a portfolio across therapeutic categories at lower cost than branded equivalents.


Cristália's oncology-ingredients operation running Latin America's first high-potency oncology API plant, opened in 2019.


Oncology portfolio of chemotherapies and targeted therapies described as Brazil's largest chemotherapy offering.


Central nervous system portfolio covering antidepressants, anticonvulsants, migraine, ADHD, and neurodegeneration medicines.


Prescription cardiometabolic medicine portfolio covering hypertension, arrhythmia, dyslipidemia, thrombosis, and diabetes.
Medley manufactures generic medicines in Brazil, offering a portfolio across therapeutic categories at lower cost than branded equivalents.

Cristália's oncology-ingredients operation running Latin America's first high-potency oncology API plant, opened in 2019.

Oncology portfolio of chemotherapies and targeted therapies described as Brazil's largest chemotherapy offering.

Central nervous system portfolio covering antidepressants, anticonvulsants, migraine, ADHD, and neurodegeneration medicines.

Prescription cardiometabolic medicine portfolio covering hypertension, arrhythmia, dyslipidemia, thrombosis, and diabetes.
